Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Lumos Diagnostics (ASX:LDX): FebriDx Point-of-Care Testing Achieves for Antimicrobial Stewardship

Operating within the innovative ASX biotechnology, medical technology, and healthcare services sectors, the company navigates a demanding operating landscape shaped by clinical development complexity, international regulations, and disciplined treasury management. In an evolving macroeconomic environment where institutionalCapitalselectively rewardsBalance Sheetdurability, sustainable operational runways, and tangible …

Aditi Sarkar | 02 November 2026

Compumedics (ASX:CMP): Somfit Wearable Sleep EEG Technology Unlocks Decentralised Diagnostics

While ongoing operational execution presents compelling long-term potential, prudentMarket Participantsmust evaluate the material operating and commercial risks inherent to the biotechnology and medical technology sectors. As November trading opens, market participants andEquityanalysts are closely examining enterprise progress with particular emphasis on clinical-grade home polysomnography …

Aditi Sarkar | 02 November 2026

Invex Therapeutics (ASX:IXC): Repurposed Exenatide Formulations Mean for Intracranial Hypertension

In an evolving macroeconomic environment where institutionalCapitalselectively rewardsBalance Sheetdurability, sustainable operational runways, and tangible commercial de-risking, IXC presents a distinctive operational profile. This measured operational momentum serves as a vital corporate validation step, confirming observations from earlier pre-clinical research models, translational studies, and initial …

Aditi Sarkar | 02 November 2026

Elixinol Wellness (ASX:EXL): Dual-Brand Hemp and Functional Food Scale Drives Retail Expansion

In an evolving macroeconomic environment where institutionalCapitalselectively rewardsBalance Sheetdurability, sustainable operational runways, and tangible commercial de-risking, EXL presents a distinctive operational profile. This measured operational momentum serves as a vital corporate validation step, confirming observations from earlier pre-clinical research models, translational studies, and initial …

Aditi Sarkar | 02 November 2026

Conneqt Health (ASX:CQT): Central Aortic Hemodynamic Monitoring Achieves in Preventive Cardiology

Operating within the innovative ASX biotechnology, medical technology, and healthcare services sectors, the company navigates a demanding operating landscape shaped by clinical development complexity, international regulations, and disciplined treasury management. In an evolving macroeconomic environment where institutionalCapitalselectively rewardsBalance Sheetdurability, sustainable operational runways, and tangible …

Aditi Sarkar | 02 November 2026

Alterity Therapeutics (ASX:ATH): Small-Molecule Iron Chaperones Matter for Neurodegenerative Care

Operationally, management has directed executive focus andCapitalresources toward evaluating clinical disease biomarkers in ongoing Phase 2 trials of ATH434 in multiple system atrophy. This measured operational momentum serves as a vital corporate validation step, confirming observations from earlier pre-clinical research models, translational studies, and …

Aditi Sarkar | 02 November 2026

Ceryvyn Therapeutics (ASX:CYV): Faces as Q1 FY27 Rare Disease Pipeline Momentum Builds

From a broader commercial perspective, Ceryvyn Therapeutics Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

EBR Systems, Inc (ASX:EBR) — EBR Systems Leads Wireless Cardiac Pacing Horizons Ahead of US Commercial Scale

From a broader commercial perspective, EBR Systems, Inc. operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Cynata Therapeutics (ASX:CYP): Scalable Cymerus Platform Signals for Regenerative Medicine

From a broader commercial perspective, Cynata Therapeutics Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026

Chimeric Therapeutics (ASX:CHM) — Is Expanding Next-Generation Cell Therapy Horizons

From a broader commercial perspective, Chimeric Therapeutics Limited operates as a specialized life sciences enterprise focused on addressing substantial unmet medical needs, clinical inefficiencies, and therapeutic gaps across global healthcare systems. The group's foundational commercialAssetsand scientific programs are protected by a comprehensive international intellectual …

Aditi Sarkar | 02 November 2026
Support

Hi! How can we help you today?

Loading…